Literature DB >> 33483258

Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?

Francesco Angelico1, Francesco Baratta2, Daniele Pastori3, Maria Del Ben3.   

Abstract

Entities:  

Year:  2021        PMID： 33483258     DOI： 10.1016/j.dld.2020.12.123

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  1 in total

1.  Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity.

Authors:  Rosa Lombardi; Vincenzo La Mura; Annalisa Cespiati; Federica Iuculano; Giordano Sigon; Giada Pallini; Marco Proietti; Irene Motta; Beatrice Montinaro; Elisa Fiorelli; Matteo Cesari; Alessandra Bandera; Luca Valenti; Flora Peyvandi; Nicola Montano; Marina Baldini; Anna Ludovica Fracanzani
Journal:  Intern Emerg Med       Date:  2022-06-26       Impact factor: 5.472
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.